CLIMB BIO, INC. Temporary Equity, Liquidation Preference
CLIMB BIO, INC. (CLYM) had Temporary Equity, Liquidation Preference of $0 as of 2021-12-31, per its 10-K filed 2022-03-07.
Discontinued › Balance Sheet › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2022-08-15
- 2021-12-31: Temporary Equity, Liquidation Preference $0.00.
- 2021-09-30: Temporary Equity, Liquidation Preference $0.00.
- 2021-06-30: Temporary Equity, Liquidation Preference $147.10M.
- 2021-03-31: Temporary Equity, Liquidation Preference $84.97M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-07 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-08 |
| 2021-06-30 | $147.10M 10-Q · filed 2022-08-15 |
| 2021-03-31 | $84.97M 10-Q · filed 2022-05-16 |
| 2020-12-31 | $49.89M 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |